TY - JOUR
T1 - Automated Determination of Left Ventricular Function Using Electrocardiogram Data in Patients on Maintenance Hemodialysis
AU - Vaid, Akhil
AU - Jiang, Joy J.
AU - Sawant, Ashwin
AU - Singh, Karandeep
AU - Kovatch, Patricia
AU - Charney, Alexander W.
AU - Charytan, David M.
AU - Divers, Jasmin
AU - Glicksberg, Benjamin S.
AU - Chan, Lili
AU - Nadkarni, Girish N.
N1 - Funding Information:
G.N. Nadkarni is supported by National Heart, Lung, and Blood Institute grant R01HL155915 and National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK127139.
Funding Information:
L. Chan reports consultancy agreements with Vifor Pharma, Inc.; research funding from the National Institutes of Health; and honoraria from Fresenius and is supported in part by National Institute of Diabetes and Digestive and Kidney Diseases career development grant K23DK124645. D.M. Charytan reports consultancy agreements with Allena Pharmaceuticals (Data Safety and Monitoring Board), Amgen, AstraZeneca, CSL Behring, Eli Lilly/ Boehringer Ingelheim, Fresenius, Gilead, GSK, Janssen (steering committee), Medtronic, Merck, Novo Nordisk, PLC Medical (clinical events committee), Renalytix, and Zogenix; research funding from Amgen, Bioporto for clinical trial support, Gilead, Medtronic for clinical trial support, and Novo Nordisk; expert witness fees related to proton pump inhibitors; and serves as an associate editor of CJASN. B.S. Glicksberg reports consultancy agreements with Anthem AI, GLG Research, and Prometheus Biosciences and honoraria from Virtual EP Connect. G.N. Nadkarni reports employment with Pensieve Health and Renalytix; consultancy agreements with AstraZeneca, BioVie, GLG Consulting, Pensieve Health, Reata, Renalytix AI, Siemens, and Variant Bio; research funding from Goldfinch Bio and Renalytix; honoraria from AstraZeneca, BioVie, Lexicon, and Reata; patents or royalties with Renalytix; owns equity and stock options in Pensieve Health as a cofounder and Renalytix; has received financial compensation as a scientific board member and advisor to Renalytix; serves on the advisory board of Neurona Health; and serves in an advisory or leadership role for Pensieve Health and Renalytix. K. Singh reports consultancy with Flatiron Health (as part of the scientific advisory board); research funding from Blue Cross Blue Shield of Michigan and Teva Pharmaceuticals; honoraria from Harvard University for education that K. Singh does in the Safety, Quality, Informatics, and Leadership program and their HMS Executive Education program; serves in an advisory or leadership role for Flatiron Health (paid member of the scientific advisory board); and reports other interests or relationships with Blue Cross Blue Shield of Michigan. K. Singh receives salary support through the University of Michigan for work done on the Michigan Urological Surgery Improvement Collaborative. All remaining authors have nothing to disclose.
Publisher Copyright:
© 2022 by the American Society of Nephrology.
PY - 2022/7
Y1 - 2022/7
N2 - Background and objectives Left ventricular ejection fraction is disrupted in patients on maintenance hemodialysis and can be estimated using deep learning models on electrocardiograms. Smaller sample sizes within this population may be mitigated using transfer learning. Design, setting, participants, & measurements We identified patients on hemodialysis with transthoracic echocardiograms within 7 days of electrocardiogram using diagnostic/procedure codes. We developed four models: (1) trained from scratch in patients on hemodialysis, (2) pretrained on a publicly available set of natural images (ImageNet), (3) pretrained on all patients not on hemodialysis, and (4) pretrained on patients not on hemodialysis and fine-tuned on patients on hemodialysis. We assessed the ability of the models to classify left ventricular ejection fraction into clinically relevant categories of #40%, 41% to #50%, and .50%. We compared performance by area under the receiver operating characteristic curve. Results We extracted 705,075 electrocardiogram:echocardiogram pairs for 158,840 patients not on hemodialysis used for development of models 3 and 4 and n518,626 electrocardiogram:echocardiogram pairs for 2168 patients on hemodialysis for models 1, 2, and 4. The transfer learning model achieved area under the receiver operating characteristic curves of 0.86, 0.63, and 0.83 in predicting left ventricular ejection fraction categories of #40% (n5461), 41%–50% (n5398), and .50% (n51309), respectively. For the same tasks, model 1 achieved area under the receiver operating characteristic curves of 0.74, 0.55, and 0.71, respectively; model 2 achieved area under the receiver operating characteristic curves of 0.71, 0.55, and 0.69, respectively, and model 3 achieved area under the receiver operating characteristic curves of 0.80, 0.51, and 0.77, respectively. We found that predictions of left ventricular ejection fraction by the transfer learning model were associated with mortality in a Cox regression with an adjusted hazard ratio of 1.29 (95% confidence interval, 1.04 to 1.59). Conclusion A deep learning model can determine left ventricular ejection fraction for patients on hemodialysis following pretraining on electrocardiograms of patients not on hemodialysis. Predictions of low ejection fraction from this model were associated with mortality over a 5-year follow-up period.
AB - Background and objectives Left ventricular ejection fraction is disrupted in patients on maintenance hemodialysis and can be estimated using deep learning models on electrocardiograms. Smaller sample sizes within this population may be mitigated using transfer learning. Design, setting, participants, & measurements We identified patients on hemodialysis with transthoracic echocardiograms within 7 days of electrocardiogram using diagnostic/procedure codes. We developed four models: (1) trained from scratch in patients on hemodialysis, (2) pretrained on a publicly available set of natural images (ImageNet), (3) pretrained on all patients not on hemodialysis, and (4) pretrained on patients not on hemodialysis and fine-tuned on patients on hemodialysis. We assessed the ability of the models to classify left ventricular ejection fraction into clinically relevant categories of #40%, 41% to #50%, and .50%. We compared performance by area under the receiver operating characteristic curve. Results We extracted 705,075 electrocardiogram:echocardiogram pairs for 158,840 patients not on hemodialysis used for development of models 3 and 4 and n518,626 electrocardiogram:echocardiogram pairs for 2168 patients on hemodialysis for models 1, 2, and 4. The transfer learning model achieved area under the receiver operating characteristic curves of 0.86, 0.63, and 0.83 in predicting left ventricular ejection fraction categories of #40% (n5461), 41%–50% (n5398), and .50% (n51309), respectively. For the same tasks, model 1 achieved area under the receiver operating characteristic curves of 0.74, 0.55, and 0.71, respectively; model 2 achieved area under the receiver operating characteristic curves of 0.71, 0.55, and 0.69, respectively, and model 3 achieved area under the receiver operating characteristic curves of 0.80, 0.51, and 0.77, respectively. We found that predictions of left ventricular ejection fraction by the transfer learning model were associated with mortality in a Cox regression with an adjusted hazard ratio of 1.29 (95% confidence interval, 1.04 to 1.59). Conclusion A deep learning model can determine left ventricular ejection fraction for patients on hemodialysis following pretraining on electrocardiograms of patients not on hemodialysis. Predictions of low ejection fraction from this model were associated with mortality over a 5-year follow-up period.
UR - http://www.scopus.com/inward/record.url?scp=85133845771&partnerID=8YFLogxK
U2 - 10.2215/CJN.16481221
DO - 10.2215/CJN.16481221
M3 - Article
C2 - 35667835
AN - SCOPUS:85133845771
VL - 17
SP - 1017
EP - 1025
JO - Clinical journal of the American Society of Nephrology : CJASN
JF - Clinical journal of the American Society of Nephrology : CJASN
SN - 1555-9041
IS - 7
ER -